Sustainable Investing

Health and nutrition

Health and nutrition is a theme that aims to improve the nutritional value of the food and beverages that we consume, led by a global campaign to reduce their sugar content. This aims to improve human health, principally by addressing the consequences of food that contains too much sugar or other additives. In recent decades, too much sugar in food and beverages has led to an epidemic of obesity, diabetes, and heart disease across the western world.

Food quality

Sugar content in food, along with levels of salt, trans fat, saturated fat and additives to improve taste or its shelf life durability, has risen dramatically as processed food has become mainstream. The principal problem with modern processed food is that it doesn’t contain enough fiber, omega-3 fatty acids or the micronutrients essential to maintain health. Instead, it contains too many trans fats, chemical additives and emulsifiers, salt and sugar.

A study in 2015 showed that of the average 600,000 items in the US food supply, 74% have added sugar, and of the 4,000 packaged items regularly on sales, 50% have a salt content that is higher than what doctors recommend be ingested daily. Too much trans fat leads to higher ‘bad’ cholesterol (LDL) and lower ‘good’ cholesterol (HDL), which contributes to heart disease. Improving food quality over all is seen as being essential to maintain human health, and reduce the burden of treatment issues related to poor diet and obesity on overstretched health services.

Creating returns that benefit the world we live in

Excessive sugar consumption over many years is known to be one of the potential causes of diabetes. More than 400 million people in the world now have diabetes, or one in ten of the adult population, while one third of all US adults are obese. The economic costs of obesity are estimated to be USD 2 trillion annually, or nearly 3% of global GDP. Sugar also has a direct link with Covid-19 deaths as one-third of the fatalities had diabetes, and were twice as likely to die within a week of contracting the disease than non-diabetic patients. In 2020, Robeco concluded a three-year engagement program with eight companies in the food and beverage industry that aimed to encourage them to use less sugar in their products.

Animal welfare and the overuse of antibiotics is another problematic issue, and one with which Robeco has engaged to improve standards in the meat and fish supply chains. Factory farming, in which thousands of chickens, pigs or cows are held together in a confined space, is not only harmful to the livestock, but acts as a breeding ground for diseases such as swine flu and avian flu. The extensive use of antibiotics is causing strains of deadly bacteria to become resistant to them, posing a threat to humans. Robeco has extensively engaged with companies in the meat supply chain to replace antibiotics with safer probiotics. These improve gut health in the animals and thereby reduces routine use of antibiotics to prevent diseases.

The overuse of fertilizers and other chemicals in crop production is another cause for concern, since residues of pesticides can remain in the crop once harvested and pass into the food chain. In 2018, Robeco began an engagement program with agrochemical, seed and fertilizer companies on the role they can play in developing yield-enhancing solutions for farmers, with a specific objective to support smallholder farmers.

Let's keep the conversation going

Keep track of fast-moving events in sustainable and quantitative investing, trends and credits with our newsletters.

Stay updated
Robeco

Robeco aims to enable its clients to achieve their financial and sustainability goals by providing superior investment returns and solutions.

Important information This disclaimer applies to any documents and the verbal or written comments of any person in presentations or webinars on this website and taken together is referred to herein as the “Information”. The services to which the Information relate are NOT FOR RETAIL CLIENTS - The information contained in the Website is solely intended for professional investors, defined as investors which (1) qualify as professional clients within the meaning of the Markets in Financial Instruments Directive (MiFID), (2) have requested to be treated as professional clients within the meaning of the MiFID or (3) are authorized to receive such information under any other applicable laws and must not be relied or acted upon by any other persons. This Information does not constitute an offer to sell, or a solicitation of an offer to buy, any financial product, and may not be relied upon in connection with the purchase or sale of any financial product. You are cautioned against using this Information as the basis for making a decision to purchase any financial product. To the extent that you rely on the Information in connection with any investment decision, you do so at your own risk. The Information does not purport to be complete on any topic addressed. The Information may contain data or analysis prepared by third parties and no representation or warranty about the accuracy of such data or analysis is provided.

In all cases where historical performance is presented, please note that past performance is not a reliable indicator of future results and should not be relied upon as the basis for making an investment decision. Investors may not get back the amount originally invested. Neither Robeco Institutional Asset Management B.V. nor any of its affiliates guarantees the performance or the future returns of any investments. If the currency in which the past performance is displayed differs from the currency of the country in which you reside, then you should be aware that due to exchange rate fluctuations the performance shown may increase or decrease if converted into your local currency. Robeco Institutional Asset Management B.V. (“Robeco”) expressly prohibits any redistribution of the Information without the prior written consent of Robeco. The Information is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use is contrary to law, rule or regulation. Certain information contained in the Information includes calculations or figures that have been prepared internally and have not been audited or verified by a third party. Use of different methods for preparing, calculating or presenting information may lead to different results. Robeco Institutional Asset Management B.V. is authorised as a manager of UCITS and AIFs by the Netherlands Authority for the Financial Markets and subject to limited regulation in the UK by the Financial Conduct Authority. Details about the extent of our regulation by the Financial Conduct Authority are available from us on request.